Lariam prices

Pharmacy FAQ

What is online pharmacy?

Since about the year 2000, hundreds of pharmacies have begun operating over the internet.
Many such pharmacies are, in some ways, similar to community pharmacies; the pr... more >>

What does the term "generic" mean? Do generic medications produce the same effect as the brand name medicines do?

The difference between a brand name medicine and a generic one is in the name, shape... more >>

Why are generic medicines so cheap?

Generics are much cheaper than brand-name drugs because generic companies do not have overhead cost such as research and marketing. Most generic drugs are manufac... more >>

Are generic drugs as reliable as brand name pills?

Generic drugs are tested under the same standards as brand-name drugs. Each generic drug is laboratory tested so that the same amount is absorbed i... more >>

Generic pills do not look like the brand name medication. The pills have a different name printed on them. Why?

As we have already mentioned that no manufacturer can take out a patent for a chemica... more >>

Are generic drugs patented?

No, but having a patent does not make it any more reliable.

... more >>

Loading Fresh Prices...

Rx Generic Pharmacy
Generic medications. WorldWide Delivery.
www.rx-genericpharmacy.com

	price	price per pill
Lariam (Mefloquine) 250mg x 20 Tabs	$190.00	$9.50	Order
Lariam (Mefloquine) 250mg x 28 Tabs	$263.20	$9.39	Order
Lariam (Mefloquine) 250mg x 4 Tabs	$38.80	$9.50	Order
Lariam (Mefloquine) 250mg x 12 Tabs	$115.20	$9.58	Order

Online Pharmacies

Medical News

Novo obesity drug could launch in U.S. end 2014

COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin producer is hoping the treatment for severe obesity will help to at least partly offset the delay to its next generation insulin treatment Tresiba after U.S. regulators asked for more tests. ..... more >>
Fri, 24 May 2013

Lawmaker would give FDA more oversight of drug compounding

By Toni Clarke WASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding. U.S. lawmakers, responding to a deadly meningitis outbreak in 2012, continue to wrestle with ways to regulate the pharmacies that compound large volumes of drugs for hospitals, individuals and clinics. ..... more >>
Thu, 23 May 2013

New J&J anti-depressant related to 'Special K' party drug

By Ransdell Pierson NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications. The intranasal drug, called esketamine, is closely related to a pediatric anesthetic called ketamine that has been shown in academic studies to ease symptoms rapidly in such patients, including a reduction in suicidal thoughts. Ketamine is also the active ingredient of the mood-altering party drug known as "Special K. ..... more >>
Thu, 23 May 2013

BTG says interventional medicine buys could boost sales to $1 bln

By Paul Sandle LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion. Chief Executive Louise Makin told Reuters the deals would more than double BTG's revenues in the fast-growing market of targeting specific areas rather than administering drugs to the whole body. BTG added to its liver cancer treatments by agreeing to buy the targeted therapies division of Nordion Inc for about $200 million, adding Therasphere radioactive glass beads to its chemotherapy beads unit. ..... more >>
Thu, 23 May 2013

Nebraska attorney general wants abortion clinic nurse's license revoked

By Katie Schubert OMAHA, Nebraska (Reuters) - Nebraska Attorney General Jon Bruning on Wednesday filed a petition to revoke the license of the only nurse at a controversial abortion clinic in the state for allegedly providing substandard care and improperly administering drugs. ..... more >>
Wed, 22 May 2013

Consumer Information (MedFacts):

Consumer Information (Cerner Multum):

Advanced Consumer Information (Micromedex):

Professional Monographs (FDA):

Professional Information: